Key facts
| Price (PPV) | 55 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amoxicillineacide clavulanique |
| Class | Antibacterials for systemic use |
| ATC code | J01CR02 |
| Manufacturer | SOTHEMA |
| Presentation | Boîte de 12 |
| Nature | Médicament |
| Hospital price | 34 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement des infections suivantes chez les adultes et les enfants: · sinusite bactérienne aiguë (diagnostiquée de façon appropriée), · otite moyenne aiguë, · exacerbations aiguës de bronchite chronique (diagnostiquée de façon appropriée), · pneumonie aiguë communautaire, · cystite, · pyélonéphrite, · infections de la peau et des tissus mous, en particulier cellulite, morsures animales, abcès dentaire sévère avec propagation de cellulite, · infections des os et des articulations, en particulier ostéomyélite. Il convient de tenir compte des recommandations officielles concernant l’utilisation appropriée des antibactériens.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Soclav Enfant 500 mg / 62.5 mg (SOTHEMA) contains the same active substance as Soclav Enfant 500 mg / 62.5 mg (Amoxicilline | Acide clavulanique) at the same strength, but in a different pack: Boîte de 16 at 72.80 MAD, i.e. 4.55 MAD per unit against 4.58 MAD for Soclav Enfant 500 mg / 62.5 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Soclav Enfant 500 mg / 62.5 mg | SOTHEMA | Boîte de 16 | 72.80 MAD | 4.55 / unit |
| Co-Amoxiclav SP 500 mg / 62.5 mg | AMANYS PHARMA (Ex SAHAM PHARMA) | Boite de 24 | 109.10 MAD | 4.55 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Soclav Enfant 500 mg / 62.5 mg
Soclav Enfant 500 mg / 62.5 mg belongs to the antibacterials for systemic use therapeutic class. In Morocco, this drug is marketed by SOTHEMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Soclav Enfant 500 mg / 62.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Soclav Enfant 500 mg / 62.5 mg
Answers to common questions from Moroccan patients about this drug.